STING activation promotes autologous type I interferon-dependent development of type 1 regulatory T cells during malaria

Yulin Wang,Fabian De Labastida Rivera,Chelsea L Edwards,Teija Cm Frame,Jessica A Engel,Luzia Bukali,Jinrui Na,Susanna S Ng,Dillon Corvino,Marcela Montes de Oca,Patrick T Bunn,Megan Sf Soon,Dean Andrew,Jessica R Loughland,Jia Zhang,Fiona H Amante,Bridget E Barber,James S McCarthy,J Alejandro Lopez,Michelle J Boyle,Christian R Engwerda
DOI: https://doi.org/10.1172/JCI169417
2023-10-02
Abstract:The development of highly effective malaria vaccines and improvement of drug-treatment protocols to boost antiparasitic immunity are critical for malaria elimination. However, the rapid establishment of parasite-specific immune regulatory networks following exposure to malaria parasites hampers these efforts. Here, we identified stimulator of interferon genes (STING) as a critical mediator of type I interferon production by CD4+ T cells during blood-stage Plasmodium falciparum infection. The activation of STING in CD4+ T cells by cyclic guanosine monophosphate-adenosine monophosphate (cGAMP) stimulated IFNB gene transcription, which promoted development of IL-10- and IFN-γ-coproducing CD4+ T (type I regulatory [Tr1]) cells. The critical role for type I IFN signaling for Tr1 cell development was confirmed in vivo using a preclinical malaria model. CD4+ T cell sensitivity to STING phosphorylation was increased in healthy volunteers following P. falciparum infection, particularly in Tr1 cells. These findings identified STING expressed by CD4+ T cells as an important mediator of type I IFN production and Tr1 cell development and activation during malaria.
What problem does this paper attempt to address?